|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7700 EUR | +1.05% |
|
-3.02% | -19.79% |
| 05-22 | Transgene SA Announces Board Appointments | CI |
| 04-13 | Transgene Completes Patient Randomization in Phase 2 Clinical Trial Evaluating TG4050 in Adjuvant Treatment of Head and Neck Cancer | CI |
| Market Cap | 211M 244M 194M 182M 341M 23.25B 346M 2.3B 895M 11.3B 917M 897M 39.08B | P/E Ratio 2026 * |
-5.5x | P/E Ratio 2027 * | -3.5x |
|---|---|---|---|---|---|
| Enterprise Value | 142M 164M 130M 122M 229M 15.62B 233M 1.55B 602M 7.59B 616M 603M 26.26B | EV / Sales 2026 * |
19.7x | EV / Sales 2027 * | 28.2x |
| Free-Float |
65.65% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Transgene
| 1 day | +1.05% | ||
| 1 week | -3.02% | ||
| Current month | -7.78% | ||
| 1 month | -1.28% | ||
| 3 months | -3.99% | ||
| 6 months | -14.44% | ||
| Current year | -19.79% |
| 1 week | 0.76 |  | 0.8 |
| 1 month | 0.76 | | 0.86 |
| Current year | 0.73 | | 1.03 |
| 1 year | 0.73 | | 1.5 |
| 3 years | 0.53 | | 2.03 |
| 5 years | 0.53 | | 2.99 |
| 10 years | 0.53 | | 3.79 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alessandro Riva
CEO | Chief Executive Officer | 65 | 2023-05-31 |
Lucie Larguier
DFI | Director of Finance/CFO | - | 2024-03-26 |
Simone Steiner
CTO | Chief Tech/Sci/R&D Officer | - | 2025-04-01 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 76 | 2013-06-18 | |
Alain Mérieux
BRD | Director/Board Member | 87 | 2006-12-31 |
Benoît Habert
BRD | Director/Board Member | 61 | 2010-07-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12-01 | Compagnie Merieux Alliance SAS
| Buy | Company | 38,492,172 | 28.9953% | |
| 12-01 | Compagnie Merieux Alliance SAS
| Buy | Company | 84,745,400 | 63.8367% | |
| 24-08-01 | Compagnie Merieux Alliance SAS
| Buy | Company | 30,898,876 | 23.3562% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | -3.02% | -20.78% | -61.88% | 241M | |
| +1.65% | +11.53% | +52.68% | +112.78% | 54.82B | |
| +0.03% | -1.80% | +49.57% | +43.94% | 43.27B | |
| +3.93% | +1.23% | -16.23% | -18.04% | 21.79B | |
| +5.27% | -6.87% | +6.37% | +388.48% | 19.92B | |
| +0.81% | -8.38% | +12.77% | -33.24% | 15.67B | |
| +0.53% | +6.07% | +8.13% | -39.59% | 15.26B | |
| +1.75% | +3.68% | +25.82% | +178.65% | 13.22B | |
| -5.27% | +3.89% | +90.88% | +208.02% | 11.58B | |
| -1.74% | -1.05% | +12.88% | - | 11.94B | |
| Average | +0.35% | -0.92% | +22.21% | +86.57% | 20.77B | |
| Weighted average by Cap. | +0.70% | +1.15% | +32.12% | +97.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.2M 8.34M 6.62M 6.21M 11.64M 794M 11.83M 78.64M 30.57M 386M 31.31M 30.63M 1.33B | 7.2M 8.34M 6.62M 6.21M 11.64M 794M 11.83M 78.64M 30.57M 386M 31.31M 30.63M 1.33B |
| Net income | -38.2M -44.25M -35.15M -32.96M -61.78M -4.21B -62.76M -417M -162M -2.05B -166M -162M -7.08B | -61.6M -71.35M -56.68M -53.16M -99.62M -6.79B -101M -673M -262M -3.3B -268M -262M -11.42B |
| Net Debt | -69.2M -80.15M -63.67M -59.71M -112M -7.63B -114M -756M -294M -3.71B -301M -294M -12.82B | -7.7M -8.92M -7.08M -6.64M -12.45M -849M -12.65M -84.11M -32.69M -412M -33.49M -32.76M -1.43B |
Employees
145
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 0.7700 € | +1.05% | 10,393 |
| 26-06-10 | 0.7620 € | -1.68% | 26,131 |
| 26-06-09 | 0.7750 € | +0.39% | 49,468 |
| 26-06-08 | 0.7720 € | -2.28% | 32,926 |
| 26-06-05 | 0.7900 € | +0.77% | 21,393 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7700EUR
Average target price
1.100EUR
Spread / Average Target
+42.86%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- TNG Stock
Select your edition
All financial news and data tailored to specific country editions
